| Two mechanisms of killing of Pseudomonas aeruginosa by tobramycin assessed at multiple inocula via mechanism-based modeling JB Bulitta, NS Ly, CB Landersdorfer, NA Wanigaratne, T Velkov, R Yadav, ... Antimicrobial agents and chemotherapy 59 (4), 2315-27, 2015 | 102 | 2015 |
| Novel approach to optimizing synergistic carbapenem plus aminoglycoside combinations against carbapenem-resistant Acinetobacter baumannii R Yadav, CB Landersdorfer, RL Nation, JD Boyce, JB Bulitta Antimicrobial agents and chemotherapy 59 (4), 2286-98, 2015 | 72 | 2015 |
| Prescription pattern of antihypertensive agents in T2DM patients visiting tertiary care centre in North India E Dhanaraj, A Raval, R Yadav, A Bhansali, P Tiwari International journal of hypertension 2012 (1), 520915, 2012 | 71 | 2012 |
| TGFβ2 and TGFβ3 isoforms drive fibrotic disease pathogenesis T Sun, Z Huang, WC Liang, J Yin, WY Lin, J Wu, JM Vernes, J Lutman, ... Science translational medicine 13 (605), eabe0407, 2021 | 68 | 2021 |
| Risk factors and complications of type 2 diabetes in Asians PT Rajbharan Yadav, Dhanaraj.E Current Research & Information on Pharmaceutical Sciences 9 (2), 8-12, 2008 | 59* | 2008 |
| Aminoglycoside concentrations required for synergy with carbapenems against Pseudomonas aeruginosa determined via mechanistic studies and modeling R Yadav, JB Bulitta, EK Schneider, BS Shin, T Velkov, RL Nation, ... Antimicrobial agents and chemotherapy 61 (12), 10.1128/aac. 00722-17, 2017 | 51 | 2017 |
| Optimization of synergistic combination regimens against carbapenem-and aminoglycoside-resistant clinical Pseudomonas aeruginosa isolates via mechanism-based pharmacokinetic … R Yadav, JB Bulitta, RL Nation, CB Landersdorfer Antimicrobial agents and chemotherapy 61 (1), 10.1128/aac. 01011-16, 2017 | 51 | 2017 |
| Optimization of a meropenem-tobramycin combination dosage regimen against hypermutable and nonhypermutable Pseudomonas aeruginosa via mechanism-based modeling and the hollow … CB Landersdorfer, VE Rees, R Yadav, KE Rogers, TH Kim, PJ Bergen, ... Antimicrobial Agents and Chemotherapy 62 (4), 10.1128/aac. 02055-17, 2018 | 35 | 2018 |
| Meropenem combined with ciprofloxacin combats hypermutable Pseudomonas aeruginosa from respiratory infections of cystic fibrosis patients VE Rees, R Yadav, KE Rogers, JB Bulitta, V Wirth, A Oliver, JD Boyce, ... Antimicrobial agents and chemotherapy 62 (11), 10.1128/aac. 01150-18, 2018 | 33 | 2018 |
| Conjugation of 10 kDa linear PEG onto trastuzumab Fab′ is sufficient to significantly enhance lymphatic exposure while preserving in vitro biological activity LJ Chan, DB Ascher, R Yadav, JB Bulitta, CC Williams, CJH Porter, ... Molecular Pharmaceutics 13 (4), 1229-1241, 2016 | 31 | 2016 |
| Optimization and evaluation of piperacillin-tobramycin combination dosage regimens against Pseudomonas aeruginosa for patients with altered pharmacokinetics via the hollow … R Yadav, KE Rogers, PJ Bergen, JB Bulitta, CMJ Kirkpatrick, SC Wallis, ... Antimicrobial agents and chemotherapy 62 (5), 10.1128/aac. 00078-18, 2018 | 28 | 2018 |
| Single intravenous dose of novel flurbiprofen-loaded proniosome formulations provides prolonged systemic exposure and anti-inflammatory effect P Verma, SK Prajapati, R Yadav, D Senyschyn, PR Shea, NL Trevaskis Molecular pharmaceutics 13 (11), 3688-3699, 2016 | 28 | 2016 |
| Evaluation of pharmacokinetic/pharmacodynamic model-based optimized combination regimens against multidrug-resistant Pseudomonas aeruginosa in a murine thigh infection model by … R Yadav, JB Bulitta, J Wang, RL Nation, CB Landersdorfer Antimicrobial agents and chemotherapy 61 (12), 10.1128/aac. 01268-17, 2017 | 27 | 2017 |
| Meropenem-tobramycin combination regimens combat carbapenem-resistant Pseudomonas aeruginosa in the hollow-fiber infection model simulating augmented renal clearance in … R Yadav, PJ Bergen, KE Rogers, CMJ Kirkpatrick, SC Wallis, Y Huang, ... Antimicrobial Agents and Chemotherapy 64 (1), 10.1128/aac. 01679-19, 2019 | 26 | 2019 |
| Bacillus Calmette–Guérin vaccine induces a selective serotonin reuptake inhibitor (SSRI)-resistant depression like phenotype in mice KV Kumar, A Rudra, MV Sreedhara, TS Subramani, DS Prasad, ML Das, ... Brain, behavior, and immunity 42, 204-211, 2014 | 26 | 2014 |
| Population pharmacokinetic modeling of the enterohepatic recirculation of fimasartan in rats, dogs, and humans TH Kim, S Shin, CB Landersdorfer, YH Chi, SH Paik, J Myung, R Yadav, ... The AAPS journal 17, 1210-1223, 2015 | 25 | 2015 |
| Prescribing pattern of antidiabetic drugs and achievement of glycemic control in T2DM patients tertiary care hospital in North India E Dhanaraj, AD Raval, R Yadav, A Bhansali, P Tiwari International Journal of Diabetes in Developing Countries 33, 140-146, 2013 | 20 | 2013 |
| Oncostatin M expression induced by bacterial triggers drives airway inflammatory and mucus secretion in severe asthma SE Headland, HS Dengler, D Xu, G Teng, C Everett, RA Ratsimandresy, ... Science translational medicine 14 (627), eabf8188, 2022 | 19 | 2022 |
| An integrated approach for characterizing immunogenic responses toward a bispecific antibody S Cohen, S Chung, C Spiess, V Lundin, E Stefanich, ST Laing, V Clark, ... MAbs 13 (1), 1944017, 2021 | 13 | 2021 |
| Factors Influencing Magnitude and Duration of Target Inhibition Following Antibody Therapy: Implications in Drug Discovery and Development RYPM Chimalakonda A AAPS 15 (3), 717-27, 2013 | 13 | 2013 |
Jurgen BulittaUniversity of Florida在 bulitta.com 的电子邮件经过验证
